<p>Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

Published:2019-08 Issue: Volume:Volume 9 Page:33-43
ISSN:1179-9889
Container-title:Blood and Lymphatic Cancer: Targets and Therapy
language:en
Short-container-title:BLCTT

Author:

Zhang Fangwen,Li Ling,Zhang Lei,Li Xin,Fu Xiaorui,Wang Xinhua,Wu Jingjing,Sun Zhenchang,Kong Fei,Ren Liangliang,Zhang Mingzhi

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis;Frontiers in Oncology;2023-07-20

3. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma;Experimental Biology and Medicine;2023-02-27

4. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study;Journal of Hematopathology;2022-12

5. CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China;Journal of International Medical Research;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP